Stay updated on Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page

  1. Check
    8 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a newer release of the page/template rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-07-25T23:57:37.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, indicating a small internal update to the site's underlying system. It does not modify the study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-04T08:20:32.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A newer revision number (v3.6.2) is now shown, indicating a behind-the-scenes update to the site. This update does not modify the study information displayed on the page.
    Difference
    0.0%
    Check dated 2026-06-27T05:34:57.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    New navigation/help sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and a version update indicates v3.6.0. The investigator name presentation and related metadata were adjusted (e.g., William Gradishar entry and related labels).
    Difference
    1%
    Check dated 2026-06-13T00:20:30.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a minor page update or bug fix. It does not appear to modify the study details, eligibility criteria, or results on the page.
    Difference
    0.1%
    Check dated 2026-06-05T22:04:45.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4. This update is a metadata/version bump and does not change the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-05-15T14:19:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.